Program Director: J. MONSONEGO (France)
TC1 / 1 - HIGH-RISK AND LOW RISK HPV INFECTIONS: THE BASIC DIFFERENCES
8:00 - 9:15
Chairman : X. BOSCH (Spain)
- Molecular Biology: Basic Differences
- Distinct Epidemiology and Natural History
- Different Immune Recognition
- Different Managing and Patient Counselling
TC1 / 2 - METHODS FOR HPV DETECTION
9:15 - 10:15
Chairman : C. MEIJER (Netherlands)
- Hybrid capture technology
- PCR methods
- Molecular marker
- RNA technology
TC1 / 3 - HPV TESTING AND PATIENT MANAGEMENT
10:45 - 11:45
Chairman : T. COX (USA)
- Screening
- Management
- Interpretation of HPV test results
TC1 / 4 -MORPHOLOGICAL DIAGNOSIS AND TREATMENT DECISIONS
14:00 - 15:15
Chairman : A. FERENCZY (Canada)
- Cytology; conventional and new techniques
- Histology (USA)
- Histology (EUROPE)
- Colposcopy
- Basic treatment options (CIN, WARTS)
TC2 - PREVENTION BY VACCINES: CURRENT STATUS, IMPACT AND PROSPECTS
15:45 - 17:30
Chairman : D. HARPER (USA)
- Rationale for HPV vaccines
- Immunogenicity and safety
- HPV vaccine efficacy
- Assessment and follow up of HPV vaccine efficacy
- Cost-effectiveness of vaccination programmes
- Unresolved issues and future expectations
- Public health issues related to HPV vaccines
- How to implement HPV vaccines in practice
TC3 - COLPOSCOPY COURSE
Program Director : A. SINGER (UK)
Chairmen : E. DIAKOMANOLIS (Greece), H. JONES (US)
TC3 / 1 - DIAGNOSIS OF CIN
08:00 – 09:30
- Educational lecture
- Colposcopy of the normal cervix
- Colposcopy of the abnormal cervix
- (CIN and HPV infection) and new nomenclature
- Grading colposcopic features
- Colposcopy of glandular lesions
TC3 / 2 - TREATMENT OF CIN
09:30-10:15
- How to treat ? W. PRENDIVILLE (Ireland)
- Results – Complications- Follow-up E. DIAKOMANOLIS (Greece)
TC3 / 3 - INTERACTIVE COURSE : Case studies
10:45-11:45
TC4 - VULVAR DISEASES COURSE
Program Director : R.W. JONES (New Zealand)
Chairmen : M. ROY (Canada), J. BORNSTEIN (Israël)
TC4 / 1 - VULVAR DISEASES COURSES : PART 1
14:00- 15:15
- Educational lecture
- The vulva : from normal to disease
- Vulvodynia, State of the Art
- Vulvar pruritus : what to do when nothing helps
TC4 / 2 - VULVAR DISEASES COURSES : PART II
15:45-17:30
- Genital Herpes : new guidelines
- Lichen sclerosus and vulvar hyperplasia
- Diagnosis and treatment of VIN
- How to manage genital warts ?
- Psychosomatic issues of vulvar diseases
TC5 - CYTOPATHOLOGY COURSE
Program Directors : E. MC GOOGAN (UK),
M. AUSTIN (US), R. RICHART (US)
TC5 / 1 - CYTOPATHOLOGY COURSE – PART I
08:00-10:00
- Educational lecture
- Basic issues and terminology
- Liquid-based cytology
- Computer-assister automation
- Proliferation and differentiation markers
- Molecular techniques for cytodiagnosis
TC5 / 2 - CYTOPATHOLOGY COURSE – PART II
10:30-11:30
Interactive Case Studies : with the contribution of the experts
TC6 - MOLECULAR MARKERS OF
CIN AND CERVICAL CARCINOMA
Program Director : Von KNEBEL-DĂ–BERITZ (Germany)
Chairmen : K. SYRJANEN (Finland), C. MOUGIN (France)
14:00 – 15:15
- Educational lecture
- Chromosomal signatures
- HPV DNA testing for prediction of CIN –HC2 versus Amplicor
- Clinical value of genotyping : the role of specific types as a marker for progression
15:45
- Viral load
- Microarray technology
- P16
- mRNA technology
- TRIPATH technology
TC7 - OFFICE GYNAECOLOGICAL IMAGING
Program Director : J.L. MERGUI (France)
Chairs : L. PARDAL (Portugal), W. PRENDIVILLE (Ireland)
TC7 / 1 – LOWER GENITAL TRACT
08:00-10:30
- Digital colposcopy
- ECC biopsy versus endocervical brushing
- Indications and modalities of CO2 laser
- LLETZ, SWETZ
- Variloop
- Cryotherapy
- Treatment of vaginal disease
- Duo-Brush : a new device for conventional and liquid-bases Pap test sampling
TC7 / 2 – ENDOMETRIUM
11:00-11:45
- Hysterosonography versus hysteroscopy
- 3D ultrasound versus 2D vaginal scanning
- Adnexal diseases : suspicious signs
- Management of post-menopausal bleeding
- Hysteroscopic treatment of synechias
- Office hysteroscopy : is it possible during consultation ?
- Assessment of the endometrium : role of the Pipelle
- The first oestroprogestin combination in 24 day scheme : endometrial features